Dechert advised Chamarel Associates

on a £115.8m syndicated facility underwritten by Halifax and Nationwide Building Society, advised by Rowe & Maw (Nigel Walsh).
Slaughter and May advised Shire Pharmaceuticals Group on a $350m ($240.7m) issue of convertible bonds, with lead managers Goldman Sachs and Bear Stearns advised by Cleary Gottlieb Steen & Hamilton (Ashar Qureshi).